These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 23996296)
1. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296 [TBL] [Abstract][Full Text] [Related]
2. LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis. Hu S; Liu J; Feng S; Wang Y; Liu H Aging (Albany NY); 2021 Apr; 13(9):12479-12492. PubMed ID: 33902004 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188 [TBL] [Abstract][Full Text] [Related]
4. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma. Su X; Wan Y; Xie L; Lin X; Zhao H; Ju X; Fang A Med Sci Monit; 2019 Sep; 25():6691-6701. PubMed ID: 31489957 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma. Zhou Y; He P; Xie X; Sun C Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911 [TBL] [Abstract][Full Text] [Related]
6. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer. Zhang Y; Li Y; Han L; Zhang P; Sun S Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer. Na-Er A; Xu YY; Liu YH; Gan YJ Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903 [TBL] [Abstract][Full Text] [Related]
8. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS. Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance. Zhu S; Mao J; Shao Y; Chen F; Zhu X; Xu D; Zhang X; Guo J Tumour Biol; 2015 Sep; 36(10):8041-5. PubMed ID: 25971582 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Sun W; Wu Y; Yu X; Liu Y; Song H; Xia T; Xiao B; Guo J Tumour Biol; 2013 Oct; 34(5):2697-701. PubMed ID: 23645148 [TBL] [Abstract][Full Text] [Related]
12. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells. Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803 [TBL] [Abstract][Full Text] [Related]
13. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker. Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481 [TBL] [Abstract][Full Text] [Related]
14. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Xu C; Shao Y; Xia T; Yang Y; Dai J; Luo L; Zhang X; Sun W; Song H; Xiao B; Guo J Tumour Biol; 2014 Oct; 35(10):9701-6. PubMed ID: 24969565 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance. Lin X; Yang M; Xia T; Guo J Med Oncol; 2014 Jul; 31(7):42. PubMed ID: 24984296 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the long noncoding RNA RP11-19P22.6-001 in gastric cancer. Sun W; Mo X; Li T; Xie Y; Guo J Cancer Biomark; 2017; 18(4):397-403. PubMed ID: 28128738 [TBL] [Abstract][Full Text] [Related]
17. The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer. Ma H; Ma T; Chen M; Zou Z; Zhang Z Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29523596 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of long noncoding RNA M26317 correlates with tumor progression and poor prognosis in gastric cancer. Li L; Wang YY; Mou XZ; Ye ZY; Zhao ZS Hum Pathol; 2018 Aug; 78():44-53. PubMed ID: 29698700 [TBL] [Abstract][Full Text] [Related]
19. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA C21orF96 Promotes the Migration, Invasion and Lymph Node Metastasis in Gastric Cancer. Yang Z; Zhi Q; Wang D; Zhang L; Preston B; Brandon C; Kuang Y; Miao R; Shi Y; Guo X Anticancer Agents Med Chem; 2016; 16(9):1101-8. PubMed ID: 26567621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]